London-based AI company Basecamp Research secures $60m Series B funding led by Singular and partners with Broad Institute for programmable genetic medicine development.

Basecamp Research, a London-based AI company, has secured $60 million in a Series B funding round led by Singular and entered a partnership with the Broad Institute of MIT and Harvard. This collaboration aims to develop innovative programmable genetic medicines. The funding will help Basecamp enhance its extensive biological database and AI capabilities, ultimately aiding drug discovery and agricultural research. Total funding now reaches $85 million.

October 09, 2024
6 Articles